Table 1

Characteristics of patients with multiple sclerosis

					Leg length (m)		Fatigue rating
Patient	Sex	Age (y)	Height (m)	Weight (kg)	Left	Right	am	pm	EDSS	Duration of MS (y)	Medication
1	F	27	1.57	61.8	0.73	0.73	0	0	3.5	7	Nil
2	F	55	1.69	57.5	0.81	0.81	0	0	5.5	8	Betaferon
3	F	49	1.65	72.2	0.78	0.78	6	6	3.5	9	Nil
4	M	36	1.81	90.8	0.87	0.87	6	5.5	3.5	6	Betaferon
5	M	52	1.69	83.4	0.81	0.81	0	1	4.5	17	Betaferon
6	M	26	1.89	78.2	0.88	0.88	4.5	6	2.5	1	Betaferon
7	M	34	1.69	74.2	0.73	0.75	3	5	4.5	15	Tegretol
8	M	46	1.78	75.6	0.91	0.91	5	8	4.5	1	Betaferon
9	M	42	1.79	72.6	0.88	0.87	0	3	4.5	4	Cortisone
10	F	32	1.61	57.0	0.84	0.83	2	2	3.0	4	Betaferon
11	F	37	1.72	63.7	0.84	0.84	3	4	3.0	2	Betaferon
12	F	65	1.73	64.0	0.84	0.84	5	7	4.0	6	Nil
13	F	26	1.52	60.8	0.69	0.69	0	0	3.5	1	Nil
14	F	23	1.66	61.6	0.81	0.81	0.5	5	3.0	6	Betaferon